Citing Stigma of Mental Illness, Weil Family Donates $185 Million for Neuroscience Center at U.C.S.F

By |2016-04-26T14:41:09-07:00April 26th, 2016|We Know Psychiatry|

The philanthropists, Sanford I. Weill and his wife, Joan, have made the largest donation in the University of California, San Francisco's  (UCSF) history, to finance a neuroscience center to provide "research on the brain, which is the most complex part of the human body," and is far behind other areas [...]

Risky, Addictive Behavior the Study of New Stanford Research

By |2016-03-24T16:58:48-07:00March 24th, 2016|We Know Psychiatry|

A prominent Stanford neuroscientist and psychiatrist, and his colleagues gives some clues about what makes some people risk-averse and others risk-taking. Answers could have implications for how to treat, curb or prevent destructively risky behavior, like pathological gambling or drug addiction.. The study, published Wednesday in the journal Nature, reports [...]

Marijuana-Based Drug Found to Reduce Epileptic Seizures

By |2016-03-15T01:21:47-07:00March 15th, 2016|We Know Psychiatry|

The New York Times will report tomorrow that an experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced on Monday, a finding that could lend credence to the medical marijuana movement. The developer, GW Pharmaceuticals, Epidiolex, achieved the [...]

Medical Advertising in the Crosshairs

By |2016-02-29T16:31:12-08:00February 29th, 2016|We Know Psychiatry|

In the summer of 1997, I was months away from launching the first consumer magazine about mental illness. My company had acquired a state and federal trademark for the title, Mental Fitness (The Science of Mental Wellness). I had done a long interview with the veteran 60 Minutes journalist, Mike [...]

5 Accused of Stealing Drug Secrets From GlaxoSmithKline

By |2016-01-21T16:32:06-08:00January 21st, 2016|We Know Psychiatry|

Federal prosecutors in Philadelphia said on Wednesday that they had indicted five people, including two research scientists, on charges of stealing trade secrets about drugs to treat cancer and other diseases from GlaxoSmithKline, the British drug giant, according to today's New York Times According to prosecutors, the two scientists, Yu [...]

Title

Go to Top